AVITA Medical (AVHHL) Equity Average (2019 - 2025)

AVITA Medical has reported Equity Average for 7 years, with the latest figure at -$11.7 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average fell 239.4% year-over-year to -$11.7 million; the trailing twelve-month figure through Dec 2025 stood at -$11.7 million (down 239.4% YoY), and the FY2025 full-year result was -$6.1 million, down 122.69% from the prior year.
• Equity Average for Q4 2025 stood at -$11.7 million, down from -$9.8 million in the prior quarter.
• The five-year high for Equity Average was $117.3 million in Q2 2021, with the low at -$11.7 million in Q4 2025.
• Historically, Equity Average has averaged $57.1 million across 5 years, with a median of $69.5 million in 2023.
• Annual changes were most pronounced in 2021 — Equity Average soared 72.78% — and 2025, when it tumbled 239.4%.
• AVITA Medical's Equity Average stood at $108.1 million in 2021, then dropped by 20.08% to $86.4 million in 2022, then plunged by 35.14% to $56.0 million in 2023, then tumbled by 85.07% to $8.4 million in 2024, then plunged by 239.4% to -$11.7 million in 2025.
• The last three Equity Average figures came in at -$11.7 million (Q4 2025), -$9.8 million (Q3 2025), and -$8.7 million (Q2 2025), per Business Quant data.